Author Correction: A phase I clinical trial for [(131)I]meta-iodobenzylguanidine therapy in patients with refractory pheochromocytoma and paraganglioma

Detalles Bibliográficos
Autores principales: Wakabayashi, Hiroshi, Inaki, Anri, Yoshimura, Kenichi, Murayama, Toshinori, Imai, Yasuhito, Higuchi, Tetsuya, Jinguji, Megumi, Shiga, Tohru, Kinuya, Seigo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Author Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8770502/
https://www.ncbi.nlm.nih.gov/pubmed/35046473
http://dx.doi.org/10.1038/s41598-022-05239-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8770502/
https://www.ncbi.nlm.nih.gov/pubmed/35046473
http://dx.doi.org/10.1038/s41598-022-05239-2

Ejemplares similares